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9 Abstract
10 We aimed to investigate life-course factors associated with blood pressure (BP) among Ugandan adolescents. Between 9th
11 April 2003 and 24th November 2005, 2507 pregnant women from Entebbe municipality and Katabi sub-county were
12 enrolled into a deworming trial. The resulting 2345 live-born offspring were followed to age 10 or 11 years, when between
13 20th May 2014 to 16th June 2016, BP was measured following standard protocols. Factors associated with BP were assessed
14 using multivariable linear regression. BP was measured in 1119 adolescents with a median age of 10.2 years. Mean systolic
15 BP and diastolic BP was 105.9 mmHg (standard deviation (SD) 8.2) and 65.2 mmHg (SD 7.3), respectively. Maternal
16 gestational body mass index (BMI), higher maternal education status and family history of hypertension were positively
17 associated with adolescent BP. Childhood (age ≤5 years) malaria was associated with lower adolescent systolic BP. Factors
18 measured at time of BP measurement positively associated with systolic BP were age, BMI, waist circumference and
19 Trichuris (whipworm) infection; higher vegetable consumption was associated with lower systolic BP. Results for diastolic
20 BP were similar, except higher fruit, rather than higher vegetable consumption was associated with lower diastolic BP and
21 there was no association with waist circumference or Trichuris infection. In summary, life-course exposures were associated
22 with adolescent BP in this tropical birth cohort. Malaria early in life could impact later BP. Interventions initiated early in life
23 targeting individuals with family history of hypertension, aiming to reduce adiposity (in pregnancy and adolescence) and
24 promoting fruit and vegetable consumption might contribute to reducing the risk of high BP and subsequent CVDs.
25Introduction
26Once uncommon in Africa [1], high blood pressure (BP)
27and cardiovascular diseases (CVDs) have escalated on the
28continent over recent decades [2], affecting populations at
29younger ages than in more afﬂuent countries [3], The rising
30burden of high BP in Africa has been attributed to a tran-
31sition from active to more sedentary lifestyles and a rise in
32unhealthy dietary practices [2]. Data on individual level BP
33risk factors in African adolescents and children are sparse. Q1
34Although high BP is less common in children and ado-
35lescents than in adults, it initiates early in life, persists into
36adulthood [4] and predicts adulthood hyperte Q2nsion [5].
37Diagnosis of CVDs is uncommon until middle-age, yet its
38antecedents, mainly cardiovascular and metabolic changes,
39begin early in life [6]. Globally, the high BP burden in
40younger ag Q3e groups has risen [7], with estimated prevalence
41of 1–25% among African children and adolescents [8].
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42 Severe persistent high BP is associated with increased
43 risk of stroke and hQ4 eart failure [9]; treatment reduces long-
44 term sequelae [9]. In children and adolescents, high BP is
45 often asymptomatic and unnoticed, despite international
46 recommendations for regular BP measurement from three
47 yearQ5 s of age [10]. Hypertension diagnosis is commonly
48 missed or inaccurately classiﬁed in children and adolescents
49 [11]. Consequently, over 75% of high BP among children
50 and adolescents remains undiagnosed worldwide [12].
51 Earlier studies, mainly in adults, have demonstrated the
52 role of established risk factors for high BP such as obesity
53 [13] and physical activity [14]. There is little literature on
54 childhood and adolescent BP determinants from Africa; in
55 particular the impact of childhood infections (of special
56 importance in Africa) remains understudied and unknown.
57 Childhood and adolescence are opportune periods for
58 high BP control or prevention before clinical manifestation
59 of hypertension or related CVDs. Identiﬁcation of life-
60 course BP risk factors unique to Africa is needed for the
61 development of appropriate BP control strategies. We used
62 longitudinally collected data from the Entebbe Mother and
63 Baby Study (EMaBS), a large tropical birth cohort, to
64 describe factors associated with adolescent BP.
65 Methods
66 Study design, setting and population
67 This longitudinal observational study investigated perinatal
68 and life-course factors associated with BP among adoles-
69 cents born in Wakiso district, Uganda. The EMaBS was a
70 randomised double-blind placebo-controlled factorial trial
71 [ISRCTN32849447], designed to investigate effects of
72 worms and their treatment in pregnancy and childhood on
73 response to childhood vaccines and on infections [15].
74 The study was conducted in Entebbe municipality and
75 Katabi sub-county (a peninsula on the northern shores of
76 Lake Victoria). In 2003–2005, 2507 women attending
77 Entebbe Hospital antenatal clinic, in their second or third
78 trimester were invited, enrolled and randomised to receive
79 albendazole (400 mg) or placebo and praziquantel (40 mg/
80 kg) or placebo [15].
81 Data were collected prenatally from women and resulting
82 2345 live-born offspring followed from birth. As previously
83 described [16], at 15 months offspring were randomised to
84 receive quarterly single-dose albendazole or placebo up to
85 age ﬁve years. Disease events were recorded at the study
86 clinic annually and when the child reported to the clinic
87 with an illness. Children continued under follow-up (seen at
88 routine annual visits and when sick) after trial completion.
89 Between 20th May 2014 and 16th June 2016, additional
90 data, including BP measurements, anthropometry, puberty,
91physical activity and diet were collected from 10- and 11-
92year-olds. Enrolment into the BP study was postponed for
93those with malaria (fever with malaria parasites) or other
94illness until they were well after being treated by the study
95team. Clinic based ﬁeld workers conducted home visits and
96telephone calls to remind participants of their annual visit
97and also invite them to participate in the BP study. Parti-
98cipants who then attended their 10- or 11-year annual visit
99during the BP study period were then invited to enrol and
100take part in the BP study at that visit. Adolescents partici-
101pated once, on their ﬁrst 10 or 11-year annual visit occur-
102ring during the study period.
103Study procedures
104Birth weight was measured and recorded immediately after
105birth in Entebbe hospital or from child health cards for
106deliveries conducted elsewhere [17]. Weight and height at
10710/11 years were measured with scales (Seca, Hamburg,
108Germany) and stadiometers (Seca 213, Hamburg Germany),
109respectively. Waist circumference was measured to the
110nearest 0.1 cm using a Seca tape measure (Seca 201,
111Hamburg, Germany). BMI was calculated as weight in
112kilograms (kg) divided by height squared (m2). Trained
113clinicians examined and performed Tanner staging [18].
114Whole-genome genotyping of 1391 EMaBS samples was
115conducted at the Wellcome Trust Sanger Institute using
116Illumina HumanOmni2.5M-8 (‘octo’) Beadchip arrays,
117version 1.1 (Illumina Inc., San Diego, USA). Sickle-cell
118trait was imputed using a merged 1000 Genomes and
119African-speciﬁc reference panel [19].
120For participants taking part in the BP study from the 21st
121January 2015 to 23rd December 2015, extra data on fat
122mass (FM), fat-free mass (FFM) and total body water mass
123(TBW) were collected by trained nurses using a segmental
124body composition analyser machine (SBCAM) (TANITA
125BC-418, TANITA Corporation, Tokyo Japan). Brieﬂy,
126participants stood barefooted on the posterior electrode base
127while holding two anterior electrodes handles of the
128SBCAM. Fat mass index= FMI (kg)/height (m2), fat-free
129mass index= FFMI (kg)/height (m2) and total body water
130mass index= TBWI (kg)/height(m2) were computed.
131Stool and blood samples were collected from women at
132enrolment and annually from children. Stool was examined
133for helminth ova and Strongyloides larvae using Kato-Katz
134[20] and charcoal culture [21] methods, respectively. Blood
135was examined for malaria parasites using Leishman’s stains
136[16]. Modiﬁed Knott’s method [22] was used for Manso-
137nella perstans. Maternal HIV status at enrolment and chil-
138dren’s HIV status after 18 months of age were assessed
139using a rapid serial testing algorithm described elsewhere
140[21, 23]. In infancy, HIV status was determined using
141polymerase chain reaction [21].
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142 At the 10- or 11-year annual visit, three BP measure-
143 ments (at ~5 min intervals) were taken after 5 min rest using
144 automated devices (Omron M6), with appropriate sized
145 cuffs [5], by trained nurses following standard protocols
146 described elsewhere [17].
147 For clinical care purposes, means of the three systolic BP
148 and three diastolic BP measurements were calculated and
149 BP percentiles determined using Centre for Disease Control
150 height charts and 2004 updated National Health and
151 Nutrition Examination Survey BP tables speciﬁc for sex,
152 age and height [5, 10]. Those with mean systolic BP
153 or diastolic BP ≥95th percentile (“high BP”) had their
154 BP re-measured on up to two extra days, 1–2 weeks apart.
155 “Pre-hypertension” was deﬁned as systolic or diastolic BP
156 ≥90th but <95th percentile. Those with persistent high BP
157 on three different days were referred for specialist attention.
158 Lifestyle modiﬁcation was recommended for participants
159 with systolic or diastolic BP ≥90th percentile.
160 For data analysis purposes, the means of the second and
161 third systolic/diastolic BP readings on day 1 were used: day
162 1 second and third BP readings were lower than the ﬁrst BP
163 reading but similar to each other [17].
164 Ethical approval was granted by the Uganda Virus
165 Research Institute Science and Ethics Committee; the
166 Uganda National Council for Science and Technology; and
167 the London School of Hygiene and Tropical Medicine.
168 Written informed assent and consent were obtained.
169 Statistical methods
170 Data were collected on pre-coded questionnaires and ana-
171 lysed with Stata 14.2 (College Station, TX, USA). Chi-
172 squared tests (for categorical variables) and t-tests (for
173 continuous variables) were used to compare characteristics
174 of cohort members who participated and did not participate
175 in the BP study.
176 Study outcomes were mean systolic BP and mean dia-
177 stolic BP, based on the second and third day-one mea-
178 surements. The decision was made to model these two
179 continuous BP outcome variables rather than to dichotomise
180 outcomes (for example, into normal versus hypertensive) as
181 an analysis using these binary outcomes would be under-
182 powered. Maternal, perinatal and offspring life-course fac-
183 tors considered as exposures and potential confounders
184 were: maternal and adolescent socio-demographic and
185 anthropometric characteristics; EMaBS trial interventions
186 (praziquantel or albendazole); sickle-cell trait; illnesses and
187 infections from birth to time of BP measurement; and body
188 composition, puberty stage, diet, sleep pattern and physical
189 activity at time of BP measurement. Area of residence was
190 grouped into urban versus rural area using zones based on
191 topography and settlements generated from geographical
192 positioning system data [24]. Household socioeconomic
193index was generated using principal components analysis of
194building materials, household size and items owned [23].
195Birth season was dichotomised into dry (rainfall below
196monthly median) and wet (rainfall above monthly median)
197season. Malaria infection in childhood (age ≤5 years) was
198investigated as clinical malaria (history of fever within the
199last 48 h or axillary temperature ≥37.5 °C and parasitaemia)
200and asymptomatic malaria (parasitaemia without fever at
201any annual visit up to 5 years). Information on diet was
202obtained as the number of days in a typical week over the
203previous month for which a given food was consumed.
204Puberty was grouped into pre-pubertal (stage 1) or pubertal
205(stages 2–5) for breast or pubic hair development using
206Tanner methods [18].
207Linear regression analysis was used. Data satisﬁed the
208assumptions for linear regression. Crude associations were
209examined for each covariate and a 20% signiﬁcance level
210used for selecting covariates for multivariable models.
211Adolescents’ sex, age and BMI were confounders a priori.
212Multivariable analysis followed a hierarchical causal
213approach adding factors sequentially (Fig. 1).
214Because of a large proportion of missing data, puberty
215and body composition variables were not included in model
216building for other exposures but their effects were each
217adjusted for variables included in the ﬁnal multivariable
218model. Multicollinearity was assessed by considering the
219change in standard error, when potentially multicollinear
220variables were included in the same model.
221The study was approved by the Research and Ethics
222Committee of the Uganda Virus Research Institute, the
223Uganda National Council for Science and Technology and
224the London School of Hygiene & Tropical Medicine.
225Consent and assent were obtained for study participation.
226Results
227Participant characteristics
228A total of 1119 EMaBS participants were enrolled into the
229BP study: 583 (52%) were males; 1100 (98.3%) singletons;
23018 (2%) HIV positive; and 344 (31%) mixed feeding by
2316 weeks. EMaBS adolescents participating in the BP study
232were similar to non-participants, except that mothers of
233participants were more likely to be of higher education
234status or married/cohabiting; offspring were less likely
235to be HIV positive or of a multiple birth, details published
236earlier [17].
237At age 10/11 (median participant age 10.2 years (inter-
238quartile range (IQR): 10.0–10.9)), 117 (11%) were attend-
239ing boarding schools, 441 (72%) were pre-pubertal stage for
240pubic hair development and 178 (65%) of girls were pre-
241pubertal stage for breast development. Mean BMI was
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242 15.8 kg/m2 (SD 1.9) and mean waist circumference 58.1 cm
243 (SD 4.9). Body composition data were available for 176
244 (16%) participants, with mean fat mass index 2.9 kg/m2 (SD
245 1.2), fat-free mass index 12.8 kg/m2 (SD 1.4) and total body
246 water mass index 9.5 kg/m2 (SD 0.9).
247 Over the previous month, starchy staple foods, animal
248 proteins, fruit, vegetables and sugar drinks were consumed
249 on average for 6.9 days/week (SD 0.8), 2.2 days/week (SD
250 1.7), 3 days/week (SD 2.2), 3.4 days/week (SD 2.3) and
251 1.7 days/week (SD 2.1), respectively. Nearly all adolescents
252 (98%) reported adding salt to cooked food.
253 Mean systolic BP was 105.9 mmHg (SD 8.2) and mean
254 diastolic BP was 65.2 mmHg (SD 7.3). There was no
255difference in mean systolic BP (P-value= 0.971) or dia-
256stolic BP (P-value= 0.141) between males and females.
257None of the adolescents had had a prior BP measurement or
258high BP diagnosis.
259Prevalence of high BP
260Using day 1 BP readings, the prevalence of pre-
261hypertension and high BP was 63 (10.8%) and 42 (7.2%),
262respectively, among males, and 54 (10.1%) and 52 (9.7%),
263respectively, among females. After extra measurements on
264the second and third visits and taking loss to follow-up into
265account, pre-hypertension prevalence was estimated as
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266 2.2% in males and 0.7% in females; high BP prevalence
267 was 0.4% in males and 1.8% in females.
268 Risk factors for high BP
269 Tables 1 and 2 show the relationship between examined
270 characteristics and BP (systolic or diastolic) in adolescents.
271 Maternal factors crudely positively associated with adoles-
272 cent systolic BP were gestational BMI and education status;
273 both remained associated with systolic BP after adjustment
274 for other maternal factors. The trial interventions during
275 pregnancy (albendazole and praziquantel) and early child-
276 hood (albendazole) had no effect on systolic or diastolic BP.
277 Characteristics at the time of BP measurement showing a
278 crude positive association with systolic BP were age, BMI,
279 waist circumference, family history of high BP, body
280 composition variables and puberty stage covariates. In
281 multivariable analysis, systolic BP increased, on average,
282 by 1.35 mmHg, 95% CI (0.32, 2.39) for each 1-year
283 increase in adolescents’ age; by 0.78 mmHg (0.42, 1.14) per
284 unit increase in BMI; and by 0.21 mmHg (0.08, 0.35) per
285 centimetre increase in waist circumference. Family history
286 of high BP remained associated with increased SBP, β=
287 1.84 (0.12, 3.56) after adjustment for maternal and child-
288 hood factors. Body composition and puberty stage covari-
289 ates were no longer associated with systolic BP on adjusting
290 for adolescents’ age, BMI and waist circumference.
291 Lifestyle factors crudely associated with increased sys-
292 tolic BP were increased animal-protein consumption,
293 increased consumption of sugared drinks and attending a
294 boarding school rather than a day school. Increased fruit and
295 vegetable consumption were associated with reduced sys-
296 tolic BP. After adjusting for confounders, systolic BP
297 reduced, on average, by 1.13 mmHg (−2.15, −0.10) among
298 adolescents who consumed vegetables for 3–7 days/week
299 (versus 0–2 days/week).
300 Current infection with Trichuris was positively asso-
301 ciated with systolic BP after adjusting for confounders (β=
302 3.48 mmHg (0.79, 6.18)). Systolic BP dropped by
303 1.24 mmHg (−2.32, −0.17) among adolescents who had
304 malaria in childhood compared to those who had not. Both
305 clinical and asymptomatic malaria were independently
306 associated with lower BP in multivariable analysis. Weight
307 and height at 10 and 11 years of age were reduced among
308 adolescents with childhood clinical and or asymptomatic
309 malaria (Supplementary Table 1). Compared to those with
310 no asymptomatic malaria, having asymptomatic malaria in
311 childhood was associated with, on average, a 3.2 cm
312 reduction in height, 95% CI (−4.5, −2.0) and a 2.1 kg
313 reduction in weight, 95% CI (−3.0, −1.9). The effect of
314 childhood malaria on adolescent BP was weaker on
315 adjusting for adolescent BMI (Supplementary Table 2).
316Genetic data were available for 802 (72%) participants of
317whom 141 (18%) had sickle-cell trait (HbAS) and 661
318(82%) normal haemoglobin (HbAA). Sickle-cell trait was
319not associated with systolic BP (β=−0.28 mmHg (−1.79,
3201.23)), even after adjusting for age and sex. HbAS was
321inversely associated with malaria (Supplementary Table 3):
322in those with HbAA, 63% had clinical or asymptomatic
323malaria up to 5 years compared to 51% with HbAS (P=
3240.008).
325Findings for diastolic BP were broadly similar to those
326for systolic BP, with the exceptions that higher fruit rather
327than vegetable consumption was associated with lower
328diastolic BP, and there was no association with waist cir-
329cumference or Trichuris infection. No associations were
330observed between adolescent BP and any of the other fac-
331tors considered in this population (Tables 1 and 2).
332Discussion
333Persistent high BP and pre-hypertension were unusual in
334early adolescence in this setting. Maternal gestational BMI
335and education status at enrolment, participant’s family his-
336tory of hypertension, and adolescents’ age and BMI at BP
337measurement were positively associated with both systolic
338BP and diastolic BP. Malaria parasitaemia in childhood, and
339increased vegetable and fruit consumption were inversely
340associated with systolic BP and diastolic BP, respectively.
341Concurrent Trichuris infection was positively associated
342with systolic BP but not with diastolic BP. There were no
343effects of anti-helminth trial interventions (in pregnancy or
344childhood) on adolescent BP and no associations between
345prior helminth infection (in pregnancy or childhood) and
346adolescent BP.
347Our ﬁndings are consistent with several earlier studies
348[25, 26]. We have shown that consuming vegetable and
349fruits for 3–7 days/week was associated with lower systolic
350BP and diastolic BP, respectively. Our results support
351ﬁndings from a cross-sectional study that consuming fruits
352and vegetables (>400 g/day) lowers systolic BP and dia-
353stolic BP in adults [26]. We have shown a positive asso-
354ciation of BP with maternal gestational BMI, and adolescent
355BMI and waist circumference at the time of BP measure-
356ment, consistent with earlier studies [13].
357Malaria parasitaemia in childhood was associated with
358lower BP in early adolescence, consistent with ﬁndings
359from a cross-sectional study among 5–18-year-old Ugandan
360students, which reported that current asymptomatic malaria
361was associated with lower BP [25]. Our study was under-
362powered to detect the effect of current parasitaemia on BP,
363with only 22 (2.1%) adolescents had parasitaemic at the
364time of BP measurement.
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Table 1 Factors investigated for association with systolic BP among adolescents from the Entebbe Mother and Baby Study (N= 1119)
Factors Mean BP (SD) Crude β (95% CI) P-value Adjusted β (95% CI) P-value
Level 1: Maternal factors at enrolments
Age (years) 0.06 (−0.03, 0.15) 0.178 0.02 (−0.07, 0.12) 0.604
Household SES
(n= 1104)
0.23 (−0.16, 0.63) 0.245
Parity 0.04 (−0.23, 0.31) 0.751
Body mass index
(n= 1110)
0.27 (0.13, 0.42) <0.001 0.26 (0.11, 0.40) <0.001
Education status
None (n= 28) 104.5 (8.7) −0.54 (−3.65, 2.56) −0.62 (−3.77, 2.53)
Primary (n= 542) 105.0 (7.7) Reference Reference
Senior (n= 438) 106.5 (8.2) 1.45 (0.42, 2.48) 1.43 (0.39, 2.47)
Tertiary (n= 109) 108.2 (9.8) 3.19 (1.51, 4.87) <0.001 3.14 (1.45, 4.84) <0.001
Marital status
Single (n= 116) 104.7 (7.6) −1.34 (−2.92, 0.25)
Married/cohabiting (n= 967) 106.0 (8.3) Reference
Separated/widowed (n= 35) 105.3 (6.1) −0.78 (−3.56, 1.99) 0.229
Area of residence
Urban (n= 770) 106.0 (8.3) Reference
Rural (n= 336) 105.5 (8.0) −0.47 (−1.52, 0.59) 0.386
Alcohol use
No (n= 775) 105.8 (8.4) Reference
Yes (n= 343) 106.0 (7.8) 0.15 (−0.90, 1.19) 0.781
Infections
HIV
Uninfected (n= 1002) 106.0 (8.3) Reference Reference
Infected (n= 117) 104.8 (7.2) −1.17 (−2.74, 0.41) 0.146 −0.88 (−2.48, 0.72) 0.279
Asymptomatic malaria
Uninfected (n= 991) 105.8 (8.2) Reference
Infected (n= 109) 106.2 (8.6) 0.42 (−1.20, 2.05) 0.609
Schistosomiasis
Uninfected (n= 908) 105.8 (8.3) Reference
Infected (n= 204) 106.2 (7.9) 0.35 (−0.90, 1.61) 0.578
Hookworm
Uninfected (n= 662) 105.8 (8.1) Reference
Infected (n= 450) 105.9 (8.4) 0.10 (−0.89, 1.09) 0.844
Ascaris
Uninfected (n= 1084) 105.9 (8.3) Reference
Infected (n= 28) 105.7 (6.7) −0.17 (−3.27, 2.92) 0.912
Intervention one
Placebo (n= 566) 105.5 (8.2) Reference Reference
Albendazole (n= 553) 106.2 (8.3) 0.67 (−0.29, 1.63) 0.173 0.84 (−0.12, 1.80) 0.087
Intervention two
Placebo (n= 564) 106.0 (8.1) Reference
Praziquantel (n= 555) 105.8 (8.4) −0.20 (−1.16, 0.77) 0.686
Level 2: Factors in childhood
Birth weight (n= 932) 0.73 (−0.33, 1.80) 0.178 0.18 (−0.93, 1.29) 0.751
Sex
Male (n= 583) 105.9 (7.5) Reference Reference
Female (n= 536) 105.9 (9.0) −0.02 (−0.98, 0.95) 0.971 0.12 (−1.18, 0.94) 0.819
Sickle-cell trait
HbAA (n= 661) 106.0 (8.4) Reference
HbAS (n= 141) 105.8 (7.9) −0.28 (−1.79, 1.23) 0.717
Season of birth
Dry (n= 651) 106.1 (8.1) Reference
Wet (n= 468) 105.5 (8.3) −0.56 (−1.54, 0.42) 0.261
Place of delivery
Entebbe Hospital (n= 824) 105.8 (8.2) Reference Reference
Home (n= 120) 104.9 (8.6) −0.86 (−2.43, 0.71) −0.37 (−3.71, 2.96)
Others (n= 174) 106.8 (8.0) 0.95 (−0.39, 2.29) 0.166 0.90 (−0.87, 2.68) 0.582
Feeding status (6 weeks of age)
Exclusively breast fed (n= 748) 106.1 (8.2) Reference
Mixed fed (n= 344) 105.4 (8.4) −0.70 (−1.75, 0.35)
Weaned (n= 14) 105.8 (7.1) −0.28 (−4.63, 4.08) 0.430
Intervention three
Placebo (n= 553) 105.5 (8.4) Reference
Albendazole (n= 554) 106.1 (8.0) 0.61 (−0.36, 1.58) 0.218
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Table 1 (continued)
Factors Mean BP (SD) Crude β (95% CI) P-value Adjusted β (95% CI) P-value
HIV status
Unexposed (n= 1001) 106.0 (8.3) Reference
Exposed not infected (n= 100) 105.2 (7.3) −0.83 (−2.52, 0.86) −0.29 (−2.15, 1.57)
Infected (n= 18) 102.7 (6.1) −3.34 (−7.17, 0.49) 0.156 −3.85 (−7.81, 0.12) 0.157
Malaria infection below 5 years of age
Clinical or asymptomatica
None (n= 456) 106.6 (8.0) Reference Reference
Yes (n= 663) 105.3 (8.3) −1.31 (−2.29, −0.33) 0.009 −1.24 (−2.32, −0.17) 0.023
Clinical malariaa
None (n= 474) 106.6 (8.0) Reference Reference
Yes (n= 645) 105.4 (8.3) −1.19 (−2.17, −0.22) 0.016 −1.08 (−2.15, −0.02) 0.045
Episodes of clinical malariaa
None (n= 474) 106.6 (8.0) Reference Reference
1–2 (n= 382) 105.4 (8.4) −1.13 (−2.24, −0.03) −1.11 (−2.32, 0.11)
≥3 (n= 263) 105.3 (8.2) −1.28 (−2.52, −0.04) 0.026 [trend] −1.05 (−2.41, 0.31) 0.133
Asymptomatic malariaa
None (n= 983) 106.1 (8.2) Reference Reference
Yes (n= 124) 103.7 (8.0) −2.41 (−3.94, −0.88) 0.002 −1.95 (−3.70, −0.20) 0.028
Schistosomiasis
Uninfected (n= 1076) 105.9 (8.2) Reference
Infected (n= 33) 104.8 (7.9) −1.09 (−3.94, 1.76) 0.452
Ascaris
Uninfected (n= 1052) 105.9 (8.3) Reference
Infected (n= 57) 105.3 (7.3) −0.62 (−2.82, 1.57) 0.576
Hookworm
Uninfected (n= 1085) 105.9 (8.2) Reference
Infected (n= 24) 103.8 (8.9) −2.06 (−5.38, 1.27) 0.225
Trichuris
Uninfected (n= 997) 105.9 (8.2) Reference
Infected (n= 112) 105.6 (8.6) −0.28 (−1.89, 1.33) 0.731
Microﬁlaria
Uninfected (n= 1102) 105.8 (8.2) Reference
Infected (n= 8) 109.4 (8.9) 3.58 (−2.13, 9.28) 0.219
Level 3: Factors in adolescence
Age 2.12 (1.17, 3.08) <0.001 1.35 (0.32, 2.39) 0.009
Body mass index 1.27 (1.02, 1.51) <0.001 0.78 (0.42, 1.14) <0.001
Waist circumference 0.46 (0.36, 0.55) <0.001 0.21 (0.08, 0.35) 0.002
Family history
High blood pressure
No (n= 1000) 105.7 (8.1) Reference Reference
Yes (n= 105) 107.6 (8.3) 1.88 (0.24, 3.52) 0.025 1.84 (0.12, 3.56) 0.034
Diabetes
No (n= 927) 105.8 (8.0) Reference
Yes (n= 186) 106.4 (9.2) 0.69 (−0.61, 1.99) 0.296
Body composition analysisc
Fat mass index (n= 176)b 3.27 (2.29, 4.24) <0.001 1.50 (−0.38, 3.38) 0.089
Fat-free mass index (n= 176)b 1.54 (0.65, 2.43) 0.001 −0.86 (−2.25, 0.54) 0.188
Total body water index (n= 176)b 4.20 (2.97, 5.42) <0.001 2.51 (−0.24, 5.27) 0.052
Adding salt to food
No (n= 20) 106.2 (7.3) 0.36 (−3.28, 4.00)
Yes (n= 1086) 105.9 (8.2) Reference 0.846
Days a fruit is eaten/week
0–2 (n= 543) 106.3 (8.0) Reference Reference
3–7 (n= 541) 105.5 (8.5) −0.83 (−1.82, 0.15) 0.098 −0.83 (−1.84, 0.19) 0.106
Days vegetables eaten/week
0–2 (n= 461) 106.4 (8.2) Reference Reference
3–7 (n= 635) 105.5 (8.3) −0.94 (−1.93, 0.05) 0.063 −1.13 (−2.15, −0.10) 0.029
Days animal-protein eaten/week
0–2 (n= 726) 105.4 (7.8) Reference Reference
3–7 (n= 374) 106.6 (8.8) 1.17 (0.16, 2.19) 0.024 0.99 (−0.06, 2.04) 0.062
Days sugared drinks taken/week
None (n= 427) 105.4 (8.1) Reference Reference
1–3 (n= 492) 105.9 (8.0) 0.54 (−0.53, 1.61) −0.05 (−1.14, 1.05)
4–7 (n= 174) 107.2 (9.1) 1.81 (0.36, 3.26) 0.051 0.96 (−0.53, 2.44) 0.358
Days a fruit is eaten/week −0.05 (−0.27, 0.18) 0.687
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Table 1 (continued)
Factors Mean BP (SD) Crude β (95% CI) P-value Adjusted β (95% CI) P-value
Days vegetables eaten/week −0.18 (−0.39, 0.03) 0.085 −0.19 (−0.40, 0.03) 0.081
Days animal-protein eaten/week 0.21 (−0.07, 0.50) 0.138 0.10 (−0.20, 0.39) 0.502
Days starchy foods eaten/week 0.14 (−0.45, 0.73) 0.636
Days sugared drinks taken/week 0.23 (0.00, 0.46) 0.049 0.11 (−0.12, 0.35) 0.325
Breast development (girls only)b
Pre-pubertal (n= 178) 103.9 (7.8) Reference Reference
Pubertal (n= 97) 108.0 (10.5) 4.07 (1.87, 6.26) <0.001 1.17 (−1.26, 3.59) 0.318
Pubic hair developmenta
Pre-pubertal (n= 441) 104.7 (7.4) Reference Reference
Pubertal (n= 170) 106.5 (9.3) 1.83 (0.42, 3.24) 0.011 0.51 (−0.96, 1.98) 0.486
Snoring
No (n= 932) 105.8 (8.2) Reference
Yes (n= 163) 106.3 (8.2) 0.53 (−0.83, 1.90) 0.444
Duration of night sleep
<9 h (n= 306) 106.1 (8.0) Reference
9 h (n= 382) 105.8 (8.8) −0.28 (−1.51, 0.96)
>9 h (n= 405) 105.7 (7.7) −0.39 (−1.61, 0.83) 0.818
Smoking in household
No (n= 962) 106.0 (8.3) Reference Reference
Yes (n= 147) 104.9 (7.5) −1.03 (−2.46, 0.40) 0.157 −0.65 (−2.10, 0.80) 0.372
Type of school
Day (n= 117) 105.7 (7.9) Reference Reference
Boarding school (n= 719) 107.5 (10.3) 1.76 (0.19, 3.34) 0.038 0.28 (−1.38, 1.95) 0.733
Physical education at school
No (n= 385) 105.5 (8.5) Reference
Yes (n= 719) 106.0 (8.1) 0.48 (−0.54, 1.50) 0.360
Infections at BP measurement
Asymptomatic malaria
Uninfected (n= 1067) 106.0 (8.2) Reference Reference
Infected (n= 22) 103.1 (9.3) −2.85 (−6.31, 0.61) 0.106 −1.50 (−5.02, 2.02)c 0.397
Schistosomiasis
Uninfected (n= 964) 105.9 (8.3) Reference
Infected (n= 112) 105.7 (8.4) −0.25 (1.88, 1.38) 0.764
Hookworm
Uninfected (n= 1066) 105.9 (8.3) Reference
Infected (n= 10) 103.8 (10.0) −2.10 (−7.27, 3.07) 0.425
Ascaris
Uninfected (n= 1073) 105.9 (8.3) Reference Reference
Infected (n= 3) 98.7 (1.6) −7.34 (−16.65, 2.17) 0.132 −7.04 (−15.97, 1.88) 0.117
Trichuris
Uninfected (n= 1036) 105.8 (8.3) Reference Reference
Infected (n= 40) 107.9 (8.3) 2.16 (−0.46, 4.78) 0.106 3.48 (0.79, 6.18) 0.010
Model building followed the hierarchical approach, adding factors sequentially at three levels starting with the distal factors (level 1). Factors at the
same level were added to the model at the same time and considered confounders for each other and for proximal factors. A P-value < 0.20 was
used for considering the inclusions and maintenance of factors in the model
Adjusted β with 95% CI excluding 0 in bold
β linear regression coefﬁcient: mean difference in blood pressure (BP) measured in mmHg
aNot included in the model together but each was adjusted for all other model variables
bNot included in multivariable model building for other exposures because of large proportion of missing information but each was adjusted for
variables in the ﬁnal model building
cNot adjusted for body mass index because body mass index is on the causal pathway
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Table 2 Factors investigated for association with diastolic BP among adolescents from the Entebbe Mother and Baby Study (N= 1119)
Mean BP (SD) Crude β (95% CI) P-value Adjusted β (95% CI)1 P-value
(A) Maternal factors
Age (years) 0.08 (−0.00, 0.15) 0.058 0.05 (−0.03, 0.13) 0.247
Household SES (n= 1104) 0.22 (−0.13, 0.56) 0.225
Parity 0.08 (−0.16, 0.32) 0.530
Body mass index (n= 1110) 0.16 (0.03, 0.29) 0.014 0.14 (0.01, 0.27) 0.030
Education status
None (n= 28) 65.1 (9.3) 0.44 (−2.32, 3.19) 0.08 (−2.71, 2.89)
Primary (n= 542) 64.6 (6.7) Reference Reference
Senior (n= 438) 65.5 (7.5) 0.92 (0.01, 1.84) 1.00 (0.07, 1.92)
Tertiary (n= 109) 66.8 (8.0) 2.14 (0.65, 3.64) 0.023 2.08 (0.57, 3.59) 0.022
Marital status
Single (n= 116) 64.2 (6.4) −1.19 (−2.59, 0.21) −1.26 (−2.69, 0.16)
Married/cohabiting (n= 967) 65.4 (7.4) Reference Reference
Separated/widowed (n= 35) 63.5 (6.0) −1.91 (−4.36, 0.54) 0.089 −1.91 (−4.38, 0.54) 0.075
Area of residence
Urban (n= 770) 65.3 (7.5) Reference
Rural (n= 336) 64.9 (6.8) 0.49 (−1.42, 0.44) 0.302
Alcohol use
No (n= 775) 65.3 (7.5) Reference
Yes (n= 343) 65.0 (6.6) −0.34 (−1.26, 0.59) 0.477
Infections
HIV
Uninfected (n= 1002) 65.2 (7.3) Reference
Infected (n= 117) 64.9 (6.5) −0.35 (−1.74, 1.05) 0.626
Asymptomatic malaria
Uninfected (n= 991) 65.2 (7.4) Reference
Infected (n= 109) 64.9 (6.6) −0.29 (−1.73, 1.15) 0.695
Schistosomiasis
Uninfected (n= 908) 65.2 (7.1) Reference
Infected (n= 204) 65.5 (7.7) 0.31 (−0.79, 1.41) 0.579
Hookworm
Uninfected (n= 662) 65.1 (7.1) Reference
Infected (n= 450) 65.4 (7.4) 0.27 (−0.60, 1.14) 0.539
Ascaris
Uninfected (n= 1084) 65.3 (7.3) Reference
Infected (n= 28) 65.1 (5.5) −0.18 (−2.90, 2.54) 0.896
Intervention one
Placebo (n= 566) 65.0 (6.9) Reference
Albendazole (n= 553) 65.4 (7.7) 0.39 (−0.46, 1.24) 0.366
Intervention two
Placebo (n= 564) 65.4 (7.3) Reference
Praziquantel (n= 555) 65.0 (7.2) −0.44 (−1.29, 0.42) 0.315
(B) Factors in childhood
Birth weight (n= 932) 0.66 (−0.27, 1.59) 0.164 0.57 (−0.40, 1.53) 0.246
Sex
Male (n= 583) 64.9 (7.2) Reference Reference
Female (n= 536) 65.5 (7.4) 0.64 (−0.21, 1.49) 0.141 0.49 (−0.43, 1.42) 0.294
Sickle-cell trait
HbAA (n= 661) 65.4 (7.1) Reference
HbAS (n= 141) 65.5 (7.4) 0.15 (−1.16, 1.46) 0.825
Season of birth
Dry (n= 651) 65.5 (7.3) Reference Reference
Wet (n= 468) 64.7 (7.2) −0.79 (−1.65, 0.07) 0.073 0.59 (−1.52, 0.35) 0.214
Place of delivery
Entebbe Hospital (n= 824) 65.1 (7.1) Reference
Home (n= 120) 65.4 (8.5) 0.36 (−1.03, 1.76)
Others (n= 174) 65.7 (7.3) 0.61 (−0.58, 1.80) 0.564
Feeding status (6 week of age)
Exclusive Breast fed (n= 748) 65.4 (7.4) Reference
Mixed fed (n= 344) 64.7 (7.0) −0.63 (−1.56, 0.30)
Weaned (n= 14) 67.1 (4.4) 1.78 (−2.07, 5.63) 0.251
Intervention three
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Table 2 (continued)
Mean BP (SD) Crude β (95% CI) P-value Adjusted β (95% CI)1 P-value
Placebo (n= 553) 64.9 (7.0) Reference Reference
Albendazole (n= 554) 65.5 (7.5) 0.62 (−0.24, 1.47) 0.156 0.56 (−0.37, 1.48) 0.233
HIV status
Unexposed (n= 1001) 65.2 (7.3) Reference
Exposed not infected (n= 100) 65.1 (6.7) −0.12 (−1.62, 1.37)
Infected (n= 18) 63.5 (5.1) −1.71 (−5.10, 1.68) 0.609
Malaria infection below 5 years of age
Clinical or asymptomatic malariaa
No (n= 456) 65.9(7.1) Reference Reference
Yes (n= 663) 64.6 (7.3) −1.28 (−2.14, −0.41) 0.004 −1.47 (−2.41, −0.53) 0.002
Clinical malariaa
None (n= 474) 66.0 (7.2) Reference Reference
Yes (n= 645) 64.6 (7.3) −1.38 (−2.24, −0.51) 0.002 −1.33 (−2.26, −0.39) 0.005
Episodes of clinical malariaa
None (n= 474) 65.9 (7.2) Reference Reference
1–2 (n= 382) 64.5 (7.3) −1.45 (−2.42, −0.47) −1.53 (−2.59, −0.46)
≥3 (n= 263) 64.9 (7.4) −1.02 (−2.12, 0.07) 0.011 −1.03 (−2.22, 0.16) 0.015
Asymptomatic malariaa
None (n= 983) 64.5 (7.3) Reference Reference
Yes (n= 124) 64.9 (7.4) −1.45 (−2.80, −0.10) 0.035 −1.35 (−2.89, 0.18) 0.082
Schistosomiasis
Uninfected (n= 1076) 65.2 (7.3) Reference
Infected (n= 33) 64.5 (5.8) 0.67 (−3.18, 1.84) 0.602
Ascaris
Uninfected (n= 1052) 65.2 (7.3) Reference
Infected (n= 57) 64.5 (7.1) −0.75 (−2.68, 1.18) 0.445
Hookworm
Uninfected (n= 1085) 65.2 (7.3) Reference Reference
Infected (n= 24) 62.9 (5.8) −2.29 (−5.22, 0.64) 0.125 −1.79 (−4.93, 1.35) 0.261
Trichuris
Uninfected (n= 997) 65.1 (7.2) Reference
Infected (n= 112) 65.8 (7.7) 0.67 (−0.74, 2.09) 0.353
Microﬁlaria
Uninfected (n= 1102) 65.1 (7.2) Reference
Infected (n= 8) 67.3 (3.3) 2.12 (−2.91, 7.14) 0.409
(C) Factors in adolescence
Age 1.85(1.00, 2.70) <0.001 1.53 (0.63, 2.43) <0.001
Body mass index 0.28 (0.20, 0.36) <0.001 0.74 (0.42, 1.05) <0.001
Waist circumference 0.88 (0.66, 1.10) <0.001 0.07 (−0.05, 0.18) 0.279
Family history
High blood pressure
No (n= 1000) 65.0 (7.2) Reference Reference
Yes (n= 105) 66.7 (7.6) 1.65 (0.19, 3.12) 0.027 1.57 (0.08, 3.06) 0.037
Diabetes
No (n= 927) 65.2 (7.2) Reference
Yes (n= 186) 65.5 (7.8) 0.35 (−0.80, 1.49) 0.553
Body composition analysisc
Fat mass indexb (n= 176) 1.75 (0.83, 2.69) <0.001 0.87 (−0.73, 2.47) 0.255
Fat-free mass indexb (n= 176) 1.19 (0.40, 1.98) 0.003 0.28 (−0.90, 1.45) 0.622
Total body water indexb (n= 176) 2.13 (0.95, 3.30) <0.001 1.51 (−0.86, 3.88) 0.180
Adding salt to food
No (n= 20) 67.4 (6.1) 2.19 (−1.04, 5.41) 2.72 (−0.39, 5.82)
Yes (n= 1086) 65.2 (7.3) Reference 0.184 Reference 0.083
Days a fruit is eaten/week
0–2 (n= 543) 65.7 (7.1) Reference Reference
3–7 (n= 541) 64.7 (7.5) −0.98 (−1.85, −0.11) 0.028 −0.96 (−1.83, −0.10) 0.027
Days vegetables eaten/week
0–2 (n= 461) 65.4 (7.1) Reference
3–7 (n= 635) 65.1 (7.5) −0.27 (−1.15, 0.60) 0.540
Days animal-protein eaten/week
0–2 (n= 726) 65.1 (6.9) Reference
3–7 (n= 374) 65.4 (8.0) 0.30 (−0.61, 1.20) 0.523
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Table 2 (continued)
Mean BP (SD) Crude β (95% CI) P-value Adjusted β (95% CI)1 P-value
Days sugared drinks taken/week
None (n= 427) 65.0 (7.1) Reference Reference
1–3 (n= 492) 65.2 (7.4) 0.25 (−0.70, 1.20) 0.12 (−0.84, 1.08)
4–7 (n= 174) 66.0 (7.5) 1.06 (−0.23, 2.35) 0.271 0.54 (−0.75, 1.83) 0.707
Days a fruit is eaten/week
Days vegetables eaten/week 0.02 (−0.16, 0.1) 0.800
Days animal-protein eaten/week 0.14 (−0.11, 0.39) 0.284
Days starchy foods eaten/week 0.03 (−0.50, 0.55) 0.924
Days sugared drinks taken/week 0.20 (0.00, 0.41) 0.048
Breast development (girls only)b
Pre-pubertal (n= 178) 64.1 (6.1) Reference Reference
Pubertal (n= 97) 67.2 (7.9) 3.067 (1.38, 4.76) <0.001 0.98 (−0.88, 2.84) 0.281
Pubic hair developmentb
Pre-pubertal (n= 441) 64.1 (6.6) Reference Reference
Pubertal (n= 170) 66.1 (7.6) 2.04 (0.82, 3.26) 0.001 0.68 (−0.62, 1.99) 0.293
Snoring
No (n= 932) 65.1 (7.2) Reference
Yes (n= 163) 65.6 (7.8) 0.44 (−0.78, 1.66) 0.477
Duration of night sleep
<9 h (n= 306) 65.8 (7.6) Reference Reference
9 h (n= 382) 64.8 (7.1) −1.03 (−2.11, 0.06) −0.92 (−2.02, 0.18)
>9 h (n= 405) 65.2 (7.2) −0.79(−1.86, 0.28) 0.160 −0.67 (−1.76, 0.43) 0.240
Smoking in household
Non (n= 962) 65.2 (7.3) Reference
Yes (n= 147) 65.0 (6.8) −0.21 (−1.46, 1.06) 0.745
Type of school
Day (n= 117) 65.1 (7.2) Reference Reference
Boarding school (n= 719) 66.2 (7.8) 1.13 (−0.26, 2.52) 0.112 −0.24 (−1.67, 1.20) 0.737
Physical education at school
No (n= 385) 65.0 (6.9) Reference
Yes (n= 719) 65.3 (7.5) 0.32 (−0.58, 1.22) 0.482
Infections at BP measurement
Asymptomatic malaria
Uninfected (n= 1067) 65.3 (7.3) Reference
Infected (n= 22) 64.0 (5.5) −1.31 (−4.36, 1.75) 0.401
Schistosomiasis
Uninfected (n= 964) 65.2 (7.4) Reference
Infected (n= 112) 65.0 (5.8) −0.19 (−1.62, 1.24) 0.791
Hookworm
Uninfected (n= 1066) 65.2 (7.3) Reference
Infected (n= 10) 64.0 (5.9) −1.25 (−5.80, 3.30) 0.590
Ascaris
Uninfected (n= 1073) 65.2 (7.3) Reference
Infected (n= 3) 62.3 (4.3) −2.86 (−11.14, 5.42) 0.498
Trichuris
Uninfected (n= 1036) 65.1 (7.2) Reference
Infected (n= 40) 66.4 (9.4) 1.23 (−1.07, 3.54) 0.294
Model building followed the hierarchical approach, adding factors sequentially at three levels starting with the distal factors (level 1). Factors at the
same level were added to the model at the same time and considered confounders for each othQ6 er and for proximal factors. A P-value < 0.20 was
used for considering the inclusion and maintenance of factors in the model
Adjusted β for which 95% CI exclude 0 are highlighted in bold
β linear regression coefﬁcient: mean difference in blood pressure (BP) measured in mmHg
aNot included in the model together but each was adjusted for all other variables in the model
bNot included in multivariable model building for other exposures because of large proportion of missing information; but each was adjusted for
variables in the ﬁnal model building
cNot adjusted for body mass index because body mass index is on the causal pathway
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365 Sub-microscopic malaria was most likely misclassiﬁed as
366 negative in this population, since in malaria-endemic areas,
367 asymptomatic malaria often presents as sub-microscopic in
368 individuals with past malaria infection [27]. We found no
369 association between sickle-cell trait and adolescent BP;
370 contrary to the hypothesis advanced by Etyang, who used
371 sickle-cell trait as an instrumental variable in a Mendelian
372 randomisation study [28]. In the predominantly adult
373 populations from Kenya, sickle-cell trait (linked with partial
374 protection against malaria) was associated with lower BP in
375 Kiliﬁ (currently a low-moderate but historically a high
376 malaria transmission area) compared to Nairobi (no malaria
377 transmission) [29]. The differences in malaria exposure
378 intensity and participant age distribution between our study
379 and the Kenyan study could explain our contrasting results.
380 Similar to earlier studies [30, 31], childhood malaria was
381 associated with reductions in both weight and height, and
382 some of the inverse association seen in this study may be
383 explained by this mechanism, or by confounding by
384 unmeasured factors. The escalating burden of high BP has
385 coincided with the declining malaria burden on the African
386 continent [2, 32, 33]. This could be explained by the epi-
387 demiological transition process on continent, or the effect
388 could be more direct; the mechanisms remain to be
389 elucidated.
390 Current but not previous infection with Trichuris (a type
391 of soil transmitted helminth, commonly known as whip-
392 worm) was associated with increased systolic BP in early
393 adolescence. To our knowledge, no study has previously
394 reported such an association. This may reﬂect short-term
395 effects (probably arterial stiffness from inﬂammatory reac-
396 tion) or it could be a spurious ﬁnding due to the many
397 exposures included in the analysis. The effect of current
398 Trichuris infection on BP is likely not mediated through
399 increasing BMI (weight or height); there was no difference
400 in these measures between adolescents with and without
401 current Trichuris infection.
402 Unlike previous studies [34], we found no association
403 between BP and salt intake. The lack of evidence for this
404 relationship in our study could be due to measurement error
405 from self-report, or the fact that nearly everyone added salt
406 to cooked food. Measuring sodium in a 24-h urine sample
407 or in commonly consumed local foods would provide a
408 more accurate reﬂection of daily intake. Physical activity
409 was not associated with lower BP, contrary to earlier lit-
410 erature [35]; sedentary lifestyles are still fairly uncommon
411 in this population.
412 Previous studies have linked hypertension to socio-
413 economic determinants (socioeconomic status (SES), edu-
414 cation, income, urbanisation) [12, 36]. Our study is
415 consistent with a Uganda study in adults which showed that
416 BP was not associated with urban residence [37] but con-
417 trary to studies linking increased BP with low SES [36] and
418urbanisation [12]. We have shown that higher maternal
419education was associated with increased BP in adolescents,
420whereas other studies, predominantly from high-income
421countries, report an inverse association [36]. Although low
422SES and education is associated with hypertension in the
423developed world [36], the relationship may be inverse in
424less developed countries [38]. In these settings, offspring
425from more highly educated households are more likely to
426have sedentary lifestyles and unhealthy dietary practices,
427and to be obese, compared to offspring from less-educated
428households.
429Strengths of this study included its longitudinal design
430with prospectively collected data reducing recall and
431reporter bias, the use of robust BP procedures and the
432measurement of BP on up to two extra occasions in those
433with BP ≥95th percentile at the initial visit, to avoid over-
434estimation of high BP. It is unlikely that white-coat phe-
435nomenon was an issue as participants regularly attend this
436clinic for scheduled and/or illness visits. The use of digital
437machines reduced differences in BP reading between
438operators which can occur with auscultation.
439Study limitations include the possibility of residual
440confounding by unmeasured factors (such as glomerular
441ﬁltration rate (GFR)). The GFR could not be estimated as
442creatinine was only measured for a subgroup of the parti-
443cipants. The use of digital BP machines may overestimate
444BP; however, digital devices used in this study were cali-
445brated twice annually. A large number of statistical tests
446were undertaken; thus, some ﬁndings may be due to mul-
447tiplicity. However, it is reassuring that most ﬁndings are
448consistent with previous literature, albeit from different
449settings. Not inviting all adolescents (those with pre-
450hypertension or normal BP on day 1) for up to two extra
451BP measurements might have resulted in an under-
452estimation in the overall prevalence of pre-hypertension and
453hypertension. We modelled BP as a continuous outcome,
454since analysing high or pre-hypertensive BP versus normal
455BP as a binary outcome (or outcomes) would be under-
456powered, consequently our ﬁndings may not necessarily
457reﬂect associations with hypertensive disease.
458In summary, routine BP screening which is seldom
459conducted for adolescents at health care visits remains vital
460in the control and prevention of CVDs later in life. Similar
461life-course factors to those observed in high-income settings
462(such as adiposity and diet) affect both systolic BP and
463diastolic BP among African adolescents. Interventions
464during pregnancy, childhood and early adolescence could
465be vital in the control and prevention of later high BP.
466Multiple intervention strategies initiated during pregnancy
467and the early postnatal period and continued across a life-
468time could be fundamental in the control of adulthood
469hypertension and CVDs.
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470 Summary
471 What is known about the topic
472 ● High blood pressure and cardiovascular diseases
473 (CVDs) are increasing in Africa.
474 ● Scarcity of data on BP risk factors among African
475 children and adolescents.
476 ● The risk factors for high BP may differ from those seen
477 in high-income non-tropical settings.
478
479 What this paper adds
480 ● Malaria infection in childhood is associated with
481 reduced blood pressure among adolescents. Effects of
482 childhood malaria on later blood pressure may be
483 partially mediated through chronic reduction in weight
484 and height.
485 ● Current infection with Trichuris is associated with
486 increased blood pressure.
487 ● Interventions during pregnancy, childhood and early
488 adolescence could be vital in the prevention of high BP
489 later in life.
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